Lopicast - A Drug to Fight Coronavirus

▴ Lopicast - A Drug to Fight Coronavirus
Aprazer Healthcare (p) Ltd.is providng Lopicast - a lifesaving drug for coronavirus at affordable prices. Lopicast is having composition of Ritonavir 50 mg & Lopinavir 200 mg which are recommended to use in coronavirus cases

The endemic of coronavirus started from Wuhan city of China and is knocking the doors of different countries of the world. The deadly symptoms of Coronavirus have put many lives at risk in various regions of the world with maximum effect in Asia especially in China. Continuous attempts are been made to find cure for this virus however considering the growing number of cases doctors have decided to look for some unconventional remedies.

Lopinavir Ritonavir A drug developed to cure HIV infections is used in the treatment of Coronavirus cases. Two antiretroviral components lopinavir and ritonavir are protease inhibitors designed to block HIV viral replication. One hypothesis holds that the drugs could do the same with 2019-nCoV (Coronavirus) which is believed to have originated from the Chinese city of Wuhan.

LOPIKASTis a Generic version of Kaletra now recommended as a treatment for pneumonia caused by the new coronavirus known as 2019-nCoV China National Health Commission says in its updated clinical guidance. Wang Guangfa the leader of Peking University First Hospital pulmonary and critical care medicine department contracted the virus as a member of a national expert team dispatched to Wuhan. Lopinavir Ritonavir tabletskilled his disease Wang told state-run China News Service in areport(Chinese) recently.

In India Aprazer Healthcare Private Limited is a pharmaceutical company based at Delhi which is continuously evolving by providing lifesaving drugs at affordable prices. Aprazer Healthcare Private Limited markets LOPIKAST having composition of Ritonavir 50 mg and Lopinavir 200 mg. As this drug is recommended to use in Coronavirus cases the company has started exporting the product to China and other flu-prone regions at economical prices. The company offers reduced prices of this life-saving drug so that it is easily accessible. Announcing the measures taken by Aprazer Healthcare Pvt. Ltd. CEO of the Company Aprazer said At Aprazer our endeavour is to contribute by supplying the LOPIKAST tablets at the all-time low prices.

He further added that This drug at cost-effective prices will prove to be a stronger response to the prevailing crisis. As it a global emergency we have to face it together.Further he states that If a person is suffering from the expected symptoms of Coronavirus must visit doctor immediately. Lopikast shouldn;t be taken without recommendation and prescription of Physician. According to the doctors treating infected patients of Coronavirus the medicine is not a complete cure for the ailment. However after taking the medicine in combination with flu drug and HIV drug to an infected person the symptoms are expected to improve considerably.

Aprazer Healthcare Pvt. Ltd. has already begun to supply LOPIKAST tablets in the hospitals and cure centres across China. Coronavirus outbreak in China is screaming for assistance from all over the world. The sensitive approach of Aprazers is what other companies should replicate as rightly quoted by Mr. Gandhi. Sometimes profit is not a consideration.

Tags : #Coronavirus #Aprazerhealthcare #Lopicast #Healthcare

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024